Literature DB >> 9516030

Lack of acetaminophen ceiling effect on R-III nociceptive flexion reflex.

V Piguet1, J Desmeules, P Dayer.   

Abstract

OBJECTIVE: The analgesic efficacy of intravenous doses of acetaminophen (paracetamol) 0.5 g, 1 g and 2 g (administered as propacetamol) was assessed in 11 healthy subjects in a randomised, double-blind, placebo-controlled crossover study. The antinociceptive effect was assessed over 8 h by measurement of the nociceptive flexion reflex threshold (R-III) in response to selective transcutaneous electrical stimulations.
RESULTS: After acetaminophen 0.5 g, R-III increased to a mean maximum of 23% over baseline values; after 1 g to 28%, and after 2 g to 40%. The AUC(0-8 h) of the analgesic effects and the AUC(0-8 h) of plasma concentrations closely correlated and were dose-dependent: rs = 0.37, for R-III and rs = 0.94, for the plasma concentrations. Intravenous acetaminophen exerted a dose-dependent central antinociceptive effect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516030     DOI: 10.1007/s002280050386

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Naltrexone and problems in pain management.

Authors:  A P Vickers; A Jolly
Journal:  BMJ       Date:  2006-01-21

Review 2.  Oxycodone/paracetamol: a low-dose synergic combination useful in different types of pain.

Authors:  Antonio Gatti; Elisabetta Sabato; Anna Rita Di Paolo; Massimo Mammucari; Alessandro Fabrizio Sabato
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

3.  Population pharmacokinetic modelling of intravenous paracetamol in fit older people displays extensive unexplained variability.

Authors:  P Mian; M J van Esdonk; K T Olkkola; B C M de Winter; A Liukas; I Spriet; D Tibboel; M Petrovic; B C P Koch; K Allegaert
Journal:  Br J Clin Pharmacol       Date:  2018-10-25       Impact factor: 4.335

4.  Paracetamol for intravenous use in medium--and intensive care patients: pharmacokinetics and tolerance.

Authors:  Monique M de Maat; Theodorus A Tijssen; Roger J Brüggemann; Huibert H Ponssen
Journal:  Eur J Clin Pharmacol       Date:  2010-03-19       Impact factor: 2.953

Review 5.  Dose-response in direct comparisons of different doses of aspirin, ibuprofen and paracetamol (acetaminophen) in analgesic studies.

Authors:  Henry J McQuay; R Andrew Moore
Journal:  Br J Clin Pharmacol       Date:  2006-07-21       Impact factor: 4.335

6.  Hyperalgesia induced by cutaneous freeze injury for testing analgesics in healthy volunteers.

Authors:  Claude Chassaing; Jeannot Schmidt; Alain Eschalier; Jean Michel Cardot; Claude Dubray
Journal:  Br J Clin Pharmacol       Date:  2006-04       Impact factor: 4.335

Review 7.  Analgo-sedation of patients with burns outside the operating room.

Authors:  Cesare Gregoretti; Daniela Decaroli; Quirino Piacevoli; Alice Mistretta; Nicoletta Barzaghi; Nicola Luxardo; Irene Tosetti; Luisa Tedeschi; Laura Burbi; Paolo Navalesi; Fabio Azzeri
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 8.  Laparoscopic surgery: a narrative review of pharmacotherapy in pain management.

Authors:  Sari Sjövall; Merja Kokki; Hannu Kokki
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

9.  Comparative effect of intraoperative propacetamol versus placebo on morphine consumption after elective reduction mammoplasty under remifentanil-based anesthesia: a randomized control trial [ISRCTN71723173].

Authors:  Michèle Binhas; François Decailliot; Saïda Rezaiguia-Delclaux; Powen Suen; Marc Dumerat; Véronique François; Xavier Combes; Philippe Duvaldestin
Journal:  BMC Anesthesiol       Date:  2004-09-14       Impact factor: 2.217

10.  Buccal acetaminophen provides fast analgesia: two randomized clinical trials in healthy volunteers.

Authors:  Gisèle Pickering; Nicolas Macian; Frédéric Libert; J Michel Cardot; Séverine Coissard; Philippe Perovitch; Marc Maury; Claude Dubray
Journal:  Drug Des Devel Ther       Date:  2014-09-26       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.